Showing 1 - 10 of 50
Persistent link: https://www.econbiz.de/10001206184
Persistent link: https://www.econbiz.de/10014432910
Two major changes in Brazilian legislation during the 1990s reshaped the local pharmaceutical industry: the ratification of the TRIPS agreement including a provision for pipeline inventions in 1996, and a Generic Drug Act in 1999, which introduced bioequivalence tests and facilitated generic...
Persistent link: https://www.econbiz.de/10008729423
Persistent link: https://www.econbiz.de/10010406468
Persistent link: https://www.econbiz.de/10011473163
Persistent link: https://www.econbiz.de/10012161283
Persistent link: https://www.econbiz.de/10011731768
Comparative analysis of the industrial concentration and turnover of the pharmaceutical industry in Brazil for the segments of mark and generic drugs - This paper analyzes the evolution of brand-name and generic drugs structure in Brazil since 1997. After the introduction of generic drugs it was...
Persistent link: https://www.econbiz.de/10008467341
Persistent link: https://www.econbiz.de/10001540386
Persistent link: https://www.econbiz.de/10001121978